Jauffret-Roustide M - Search Results

1

Cost-effectiveness of drug consumption rooms in France: a modelling study.

Cousien A, Donadille C, Madrid LB, Maradan G, Jauffret-Roustide M, Lalanne L, Auriacombe M, Roux P, Boyer S. Cousien A, et al. Among authors: jauffret roustide m. BMC Public Health. 2024 May 28;24(1):1426. doi: 10.1186/s12889-024-18909-9. BMC Public Health. 2024. PMID: 38807111 Free PMC article.

2

[Life trajectory and risk-taking among women drug users].

Jauffret-Roustide M, Oudaya L, Rondy M, Kudawu Y, Le Strat Y, Couturier E, Emmanuelli J, Desenclos JC. Jauffret-Roustide M, et al. Med Sci (Paris). 2008 Mar;24 Spec No 2:111-21. doi: 10.1051/medsci/2008242s111. Med Sci (Paris). 2008. PMID: 18681127 Free article. French. No abstract available.

3

[Collective of users in the fields of AIDS and drug addiction].

Broqua C, Jauffret-Roustide M. Broqua C, et al. Med Sci (Paris). 2004 Apr;20(4):475-9. doi: 10.1051/medsci/2004204475. Med Sci (Paris). 2004. PMID: 15124122 Free article. Review. French.

4

[The role of a new syringe filter in harm reduction: the views of active injection drug users].

Milhet M, Jauffret-Roustide M. Milhet M, et al. Sante Publique. 2017 Jul 10;29(3):311-320. Sante Publique. 2017. PMID: 28737352 French.

5

Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy.

Michel L, Jauffret-Roustide M, Blanche J, Maguet O, Calderon C, Cohen J, Carrieri PM; ANRS PRI²DE study group. Michel L, et al. BMC Public Health. 2011 May 27;11:400. doi: 10.1186/1471-2458-11-400. BMC Public Health. 2011. PMID: 21619573 Free PMC article.

6

Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y. Cousien A, et al. Hepatology. 2016 Apr;63(4):1090-101. doi: 10.1002/hep.28227. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26390137

7

Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern.

Michel L, Lions C, Van Malderen S, Schiltz J, Vanderplasschen W, Holm K, Kolind T, Nava F, Weltzien N, Moser A, Jauffret-Roustide M, Maguet O, Carrieri PM, Brentari C, Stöver H. Michel L, et al. BMC Public Health. 2015 Oct 27;15:1093. doi: 10.1186/s12889-015-2421-y. BMC Public Health. 2015. PMID: 26507505 Free PMC article.

8

A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study.

Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. Werb D, et al. Harm Reduct J. 2016 Sep 15;13(1):25. doi: 10.1186/s12954-016-0114-1. Harm Reduct J. 2016. PMID: 27629248 Free PMC article.

9

Reply.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y. Cousien A, et al. Hepatology. 2017 Jun;65(6):2129-2130. doi: 10.1002/hep.29069. Epub 2017 Apr 18. Hepatology. 2017. PMID: 28108986 No abstract available.

10

Hepatitis C virus prevention and care for drug injectors: the French approach.

Delile JM, de Ledinghen V, Jauffret-Roustide M, Roux P, Reiller B, Foucher J, Dhumeaux D. Delile JM, et al. Hepatol Med Policy. 2018 Jun 5;3:7. doi: 10.1186/s41124-018-0033-8. eCollection 2018. Hepatol Med Policy. 2018. PMID: 30288330 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters